The arrival of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable interest within the weight loss community. This innovative dual GIP and GLP-1 agonist medication seems to deliver impressive improvements in body loss compared to previous therapies. Preliminary clinical data have demonstrated marked declines in body fat percentage, con